Aim: Acanthamoeba infections are characterized by an intense localized innate immune response associated with an influx of macrophages. Acanthamoeba protease production is known to affect virulence. Herein, the ability of Acanthamoeba trophozoite proteases, of either the laboratory Neff strain or a recently isolated clinical strain, to stimulate IL-12 and IL-6 and to activate protease-activated receptors, PAR and PAR expressed on murine macrophages, was investigated.
Method And Results: Using selected protease inhibitors, leupeptin and E64, we showed that Acanthamoeba proteases can stimulate IL-12 and IL-6 by murine macrophages. Subsequently, using specific antagonists to inhibit PAR , and bone marrow-derived macrophages from PAR gene-deficient mice, we demonstrate that PAR , but not PAR contributes to macrophage IL-12 production in response to Acanthamoeba. In contrast, Acanthamoeba-induced IL-6 production is PAR and PAR independent.
Conclusion: This study shows for the first time the involvement of PARs, expressed on macrophages, in the response to Acanthamoeba trophozoites and might provide useful insight into Acanthamoeba infections and their future treatments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/pim.12612 | DOI Listing |
PLoS One
June 2015
The Union Office in Myanmar, International Union Against Tuberculosis and Lung Disease, Mandalay, Myanmar.
Background: The outcomes from an antiretroviral treatment (ART) program within the public sector in Myanmar have not been reported. This study documents retention and the risk factors for attrition in a large ART public health program in Myanmar.
Methods: A retrospective analysis of a cohort of adult patients enrolled in the Integrated HIV Care (IHC) Program between June 2005 and October 2011 and followed up until April 2012 is presented.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!